Chronic kidney disease, all-cause mortality and cardiovascular mortality among chinese patients with established cardiovascular disease

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 4, 2010, Pages 395-401

  Yang, Jin gang ^a   Li, Jue ^b   Lu, Changlin ^c   Hasimu, Buaijiaer ^d   Yang, Yuejin ^a   Hu, Dayi ^e  

^a FUWAI HOSPITAL   (China)

^b TONGJI UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d XINJIANG MEDICAL UNIVERSITY   (China)

^e PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

All cause mortality; Cardiovascular disease; Cardiovascular mortality; Chronic kidney disease

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHINESE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART DEATH; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL VASCULAR DISEASE; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 77953524777     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.3061     Document Type: Article

References (38)

1. Koizumi J, Shimizu M, Miyamoto S, Takeda R, Ohka T, Kanaya H, Uno Y, Ueda K, Takegoshi T, Wakasugi T, Ohta M, Sumitani T, Kametani T, Watanabe A, Fujita H, Hifumi S, Origasa H, Mabuchi H: Risk evaluation of coronary heart disease and cerebrovascular disease by the Japan Atherosclerosis Society Guidelines 2002 using the cohort of the Holicos-PAT study. J Atheroscler Thromb, 2005; 12: 48-52
2. Bax L, Algra A, Mali WP, Edlinger M, Beutler JJ, van der Graaf Y: Renal function as a risk indicator for cardiovascular events in 3216 patients with manifest arterial disease. Atherosclerosis, 2008; 200: 184-190.
3. Brosius FC, 3rd, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, Pennathur S, Smith GL, Wilson PW: Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation, 2006; 114: 1083-1087
4. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, Wang H: The burden of kidney disease: improving global outcomes. Kidney Int, 2004; 66: 1310-1314
5. Hou FF: Cardiovascular risk in Chinese patients with chronic kidney diseases: where do we stand? Chin Med J (Engl), 2005; 118: 883-886
6. Wang H, Zhang L, Lv J: Prevention of the progression of chronic kidney disease: practice in China. Kidney Int Suppl, 2005: S63-67
7. Zhang L, Zuo L, Wang F, Wang M, Wang S, Lv J, Liu L, Wang H: Cardiovascular disease in early stages of chronic kidney disease in a Chinese population. J Am Soc Nephrol, 2006; 17: 2617-2621
8. Fox KA, Antman EM, Montalescot G, Agewall S, Soma-Raju B, Verheugt FW, Lopez-Sendon J, Hod H, Murphy SA, Braunwald E: The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. J Am Coll Cardiol, 2007; 49: 2249-2255
9. Shlipak MG, Simon JA, Grady D, Lin F, Wenger NK, Furberg CD: Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol, 2001; 38: 705-711
10. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS: Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med, 2002; 137: 563-570
11. Amsalem Y, Garty M, Schwartz R, Sandach A, Behar S, Caspi A, Gottlieb S, Ezra D, Lewis BS, Leor J: Prevalence and significance of unrecognized renal insufficiency in patients with heart failure. Eur Heart J, 2008; 29: 1029-1036
12. McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, Klag MJ, Bakris GL: Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med, 2007; 167: 1122-1129
13. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med, 2002; 137: 555-562
14. Wannamethee SG, Shaper AG, Perry IJ: Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke, 1997; 28: 557-563
15. Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M: Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ, 2006; 332: 1426
16. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med, 2001; 134: 629-636
17. Matsuda N, Takei T, Fujiu A, Ogawa T, Nitta K: Arterial stiffness in patients with non-diabetic chronic kidney disease (CKD). J Atheroscler Thromb, 2009; 16: 57-62.
18. Kuboyama M, Ageta M, Ishihara T, Fujiura Y, Kashio N, Ikushima I: Serum lipoprotein(a) concentration and Apo(a) isoform under the condition of renal dysfunction. J Atheroscler Thromb, 2003; 10: 283-289
19. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med, 2004; 351: 1285-1295
20. Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, Knudtson ML: The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol, 2004; 44: 1587-1592.
21. Sakaguchi K, Horimatsu T, Kishi M, Takeda A, Ohnishi Y, Koike T, Fujisawa T, Maeda M: Isolated home hypertension in the morning is associated with target organ damage in patients with type 2 diabetes. J Atheroscler Thromb, 2005; 12: 225-231.
22. Hasimu B, Li J, Nakayama T, Yu J, Yang J, Li X, Hu D: Ankle brachial index as a marker of atherosclerosis in Chinese patients with high cardiovascular risk. Hypertens Res, 2006; 29: 23-28
23. Walker AE, Robins M, Weinfeld FD: The National Survey of Stroke. Clinical findings. Stroke, 1981; 12: I13-144
24. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol, 2006; 17: 2937-2944
25. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002; 39: S1-266
26. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 1999; 130: 461-470
27. Glynn LG, Reddan D, Newell J, Hinde J, Buckley B, Murphy AW: Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study. Nephrol Dial Transplant, 2007; 22: 2586-2594.
28. Liu H, Yu J, Chen F, Li J, Hu D: Inpatients with coronary heart disease have a high prevalence of chronic kidney disease based on estimated glomerular filtration rate (eGFR) in China. Heart Vessels, 2007; 22: 223-228
29. Muntner P, He J, Hamm L, Loria C, Whelton PK: Renal insufficiency and subsequent death resulting from cardio vascular disease in the United States. J Am Soc Nephrol, 2002; 13: 745-753
30. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ: Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003; 41: 47-55
31. Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, Levey AS, Sarnak MJ: Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int, 2003; 63: 1121-1129
32. Garg AX, Clark WF, Haynes RB, House AA: Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int, 2002; 61: 1486-1494
33. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 2004; 351: 1296-1305
34. McCullough PA, Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ: Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J, 2002; 144: 226-232
35. Winkelmayer WC, Charytan DM, Brookhart MA, Levin R, Solomon DH, Avorn J: Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol, 2006; 1: 796-801
36. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ: Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol, 2001; 38: 955-962
37. Zhang L, Zuo L, Xu G, Wang F, Wang M, Wang S, Lv J, Liu L, Wang H: Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant, 2007; 22: 1093-1099.
38. Zuo L, Ma YC, Zhou YH, Wang M, Xu GB, Wang HY: Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis, 2005; 45: 463-472.